CliffBio
small molecule

ATROPINE AND DEMEROL

ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameATROPINE AND DEMEROL
Active ingredientATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE
Strength0.4MG/ML;75MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalNovember 1982
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ATROPINE AND DEMEROL patent cliff — loss of exclusivity — | CliffBio